Verification of improvement effects on sleep quality by test-food intakes - Verification of improvement effects on sleep quality by test-food intakes

CPCC Company Limited0 sites150 target enrollmentSeptember 1, 2022

ConditionsHealthy male/female adults

Overview

Phase: 未知
Intervention: Not specified
Conditions: Healthy male/female adults
Sponsor: CPCC Company Limited
Enrollment: 150
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

September 1, 2022

End Date

December 8, 2022

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

CPCC Company Limited

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•Subjects \- \- (1\) taking in sleep\-affecting foods, not less than three times a week, (2\) who will take medicines which might affect the test (e.g., sleeping pill) during the test period, (3\) with not less than 30\.0 kg/m2 of BMI, (4\) with sleep\-apnea syndrome, (5\) with previous medical history of sleep disorder, (6\) who have suffered from basal diseases, and being under medical treatment. (7\) cannot use the activity tracker during the test period, (8\) with an alcohol intake the day before the record of a sleep\-questionnaire, (9\) with not less than an overnight trip during the test period, (10\) with extremely irregular dietary habit/life rhythm, (11\) with a serious sleep\-affecting rhinitis, (12\) with excessive alcohol intake, (13\) sleeping with their family in the same room, and might be woken up by the family during sleep, (14\) with medical history of serious diseases, (15\) with pregnancy, possibly one, or lactating, (16\) with drug/food allergy, (17\) being under another clinical test (medicine or health food), or participated in that within the last 4 weeks, or will join that after the consent, (18\) who donated their blood components or blood (0\.2 L) within the last month, (19\) who donated his blood (0\.4 L) within the last 3 months, (20\) who donated her blood (0\.4 L) within the last 4 months, (21\) being collected in total of his blood (1\.2 L) within the last 12 months and in this study, (22\) being collected in total of her blood (0\.8 L) within the last 12 months and in this study, (23\) being determined as ineligible for participation by the principal/sub investigator \- \- .